• LevelJump Healthcare Corp. (JUMP) has qualified to trade on the OTCQB® Venture Market
  • Shares of Leveljump will commence trading at the open on May 12th under the symbol JMPHF
  • The OTCQB Venture Market is for entrepreneurial and development stage U.S. and international companies
  • Trading on the OTCQB Market will provide LevelJump access to the U.S. capital markets and investors
  • LevelJump Healthcare Corp. (JUMP) owns and operates Canadian Teleradiology services
  • LevelJump Healthcare Corp. (JUMP) is down 4.88 per cent, trading at C$0.195 per share at 4 pm ET

LevelJump Healthcare Corp. (JUMP) has qualified to trade on the OTCQB® Venture Market.

Shares of Leveljump will commence trading at the open on May 12th under the symbol JMPHF.

The OTCQB Venture Market is for entrepreneurial and development stage U.S. and international companies. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. Trading on the OTCQB Market is intended to offer companies efficient, cost-effective access to the U.S. capital markets.

For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the U.S.

“We are extremely proud to announce the commencement of trading on the OTCQB Venture Market,” said Mitch Geisler, CEO and Chairman of Leveljump.

“We are excited to share our vision for Leveljump with a wider pool of retail and institutional shareholders throughout the United States.”

“We are pleased to welcome Leveljump Healthcare Corp. to the OTCQB Venture Market,” said Jason Paltrowitz, EVP of Corporate Services at OTC Markets Group.

“Trading on the TSX Venture Exchange in Canada and on the OTCQB Market in the U.S. will enable Leveljump to more efficiently build global investor awareness. We look forward to supporting the company and its shareholders.”

LevelJump Healthcare Corp. (JUMP) owns and operates Canadian Teleradiology services. JUMP plans to expand through the acquisition of independent healthcare facilities focused on diagnostic imaging as well as acquiring new disruptive imaging technologies.

LevelJump Healthcare Corp. (JUMP) is down 4.88 per cent, trading at C$0.195 per share at 4 pm ET.

More From The Market Online

Avicanna launches 10% CBD (THC free) formula in Canada

Avicanna (TSX:AVCN) launches RHO Phyto Micro Drop 100, a 10 per cent CBD (THC free), proprietary oral formulation in Canada.

Theratechnologies phases down preclinical oncology research

Biopharmaceutical company Theratechnologies (TSX:TH) announced it will phase down its preclinical oncology research activities.